Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Completed · Phase 1

Conditions studied: AIDS

In brief

The purpose of this long-term follow-up study is to assess the long-term health status of HIV-infected subjects who previously participated in GSK-sponsored trials evaluating the investigational HIV vaccine 732462. This study will provide additional data concerning the long-term benefits/risks associated with vaccination. No vaccine will be administered during the study period. Vaccines were administered during the primary studies.

Key facts

Study ID

NCT01092611

Run by

GlaxoSmithKline

People needed

190

Starts

2010-03-22

Expected to finish

2014-05-19

Last updated by the study team

2018-03-02

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All subjects must satisfy ALL the following criteria at study entry:
• HIV-infected subject.
• Previous participation in a study evaluating GSK HIV vaccine 732462.
• Written informed consent obtained from the subject.

You may not qualify if…

• The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the subject must not be included in the study:
• Subjects who did not receive a complete vaccination course in previous studies.

Where it is running

• GSK Investigational Site — Bakersfield, California, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Camden, New Jersey, United States
• GSK Investigational Site — Columbus, Ohio, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Annandale, Virginia, United States
• GSK Investigational Site — Seattle, Washington, United States
• GSK Investigational Site — Bobigny, France
• GSK Investigational Site — Créteil, France
• GSK Investigational Site — Nantes, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Freiburg im Breisgau, Baden-Wurttemberg, Germany
• GSK Investigational Site — Erlangen, Bavaria, Germany
• GSK Investigational Site — Munich, Bavaria, Germany
• GSK Investigational Site — Munich, Bavaria, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.